Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Liver Cancer Diagnostic Trends and Forecast

The future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

A more than 150-page report is developed to help in your business decisions.

Liver Cancer Diagnostic by Segment

The study includes a forecast for the global liver cancer diagnostic by test type, end use, and region.

Liver Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Laboratory Tests
• Imaging
• Endoscopy
• Biopsy
• Others

Liver Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & CRO Laboratories

Liver Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Liver Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver cancer diagnostic companies profiled in this report include-

• Abbott Laboratories
• F. Hoffmann-La Roche
• Qiagen
• Thermo Fisher Scientific
• Siemens Healthineers

Liver Cancer Diagnostic Market Insights

Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Within this market, hospitaland diagnostic laboratory will remain the largest segment over the forecast period.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Features of the Global Liver Cancer Diagnostic Market

Market Size Estimates: Liver cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver cancer diagnostic market size by test type, end use, and region in terms of value ($B).

Regional Analysis: Liver cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, end uses, and regions for the liver cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the liver cancer diagnostic market size?

Answer: The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030.

Q2. What is the growth forecast for liver cancer diagnostic market?

Answer: The global liver cancer diagnostic market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the liver cancer diagnostic market?

Answer: The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

Q4. What are the major segments for liver cancer diagnostic market?

Answer: The future of the liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets.

Q5. Who are the key liver cancer diagnostic market companies?

Answer: Some of the key liver cancer diagnostic companies are as follows:

• Abbott Laboratories
• F. Hoffmann-La Roche
• Qiagen
• Thermo Fisher Scientific
• Siemens Healthineers

Q6. Which liver cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Q7. In liver cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the liver cancer diagnostic market by test type (laboratory tests, imaging, endoscopy, biopsy, and others), end use (hospitals & diagnostic laboratories, academic & research institutes, and pharmaceutical & CRO laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?